BL
BioLineRx Ltd
🇺🇸XNAS.BLRXUnited StatesHealthcare
$2.48USDup +0.05 (+2.06%)OpenDelayed3:25 PM
Price$2.48+0.05 (+2.06%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US09071M3043
- CUSIP
- 09071M205
Company
- Employees
- 20
- Headquarters
- Hevel Modi'in, United States
- Website
- https://www.biolinerx.com
- CEO
- Mr. Philip A. Serlin CPA, M.B.A.
Market
- Shares outstanding
- 4.8M
- Market cap
- $12.03M
Highlights
- Market cap
- $12.36M
- EPS LTM
- -$1.81
- P/E LTM
- -1.73
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $1.4M-91.89%down year on year
- Net income
- -$8.03M-2.65%down year on year
- Gross margin
- 69.82%+17.69%up year on year
- Free cash flow
- -$10.9M+48.57%up year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.